Genki Minegishi, Yuka Kobayashi, Mayu Fujikura, Ayane Sano, Yasuhiro Kazuki, Kaoru Kobayashi. Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics. Pharmacology research & perspectives. 2024. 12. 3. e1197
Yang Li, Yasuhiro Kazuki, Thomas Drabison, Kaoru Kobayashi, Ken-Ichi Fujita, Yue Xu, Yan Jin, Eman Ahmed, Junan Li, Eric D Eisenmann, et al. Vincristine disposition and neurotoxicity are unchanged in humanized CYP3A5 mice. Drug Metabolism and Disposition. 2024. 52. 2. 80-85
Yutaka Furutani, Yoshinori Hirano, Mariko Toguchi, Shoko Higuchi, Xian-Yang Qin, Kaori Yanaka, Yumi Sato-Shiozaki, Nobuaki Takahashi, Marina Sakai, Pornparn Kongpracha, et al. A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor. Cell Death Discovery. 2023. 9. 1. 467-467
Kiamu Kurosawa, Masataka Nakano, Itsuki Yokoseki, Mai Nagaoka, Seiya Takemoto, Yoshiyuki Sakai, Kaoru Kobayashi, Yasuhiro Kazuki, Tatsuki Fukami, Miki Nakajima. ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver. Biochemical Pharmacology. 2023. 115733-115733
Kaoru Kobayashi, Genki Minegishi, Nina Kuriyama, Atsushi Miyajima, Satoshi Abe, Kanako Kazuki, Yasuhiro Kazuki. Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Background of MouseCyp2candCyp3aGenes. Drug Metabolism and Disposition. 2023. 51. 2. 174-182
日本動物実験代替法学会
, American Society for Pharmacology and Experimental Therapeutics
, 日本薬理学会
, International Society for the Study of Xenobiotics
, 日本臨床薬理学会
, 日本薬物動態学会
, 日本薬学会